NSE IPO - Apply Online, Check Issue Date, Price, Lot Size & Allotment Status

Apply for NSE IPO:

Skip to main content

Live Arcus Biosciences, Inc. Share Price Chart

O H L

Arcus Biosciences, Inc. Performance Overview

Days Range
$25.32Low
$25.36High

Markets Today

Previous Close$25.54
Open$25.32
Volume120,309
Day's Range$25.32 - $25.36
52W RangeNA
Market Cap$3.14 B

Historical Performance

1M Returns-13.45
3M Returns+5.06
6M Returns+14.99
1Y Returns+105.31
5Y Returns-29.82
10Y ReturnsNA

Arcus Biosciences, Inc. Fundamentals

Market Cap$3.14 B
Dividend yieldN/A
PE RatioN/A
PEG RatioN/A
Revenue$247.00 M
ROE TTMN/A
EPS TTMN/A
Quarterly Earnings Growth YOYN/A
PB RatioN/A
EBITDA$-376.00 M
Profit Margin-142.91
Market Cap$3.14 B
Dividend yieldN/A
PE RatioN/A
PEG RatioN/A
Revenue$247.00 M
ROE TTMN/A
EPS TTMN/A
Quarterly Earnings Growth YOYN/A
PB RatioN/A
EBITDA$-376.00 M
Profit Margin-142.91

Arcus Biosciences, Inc. Profit & Loss

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Revenue +$28.00 M$160.00 M$26.00 M$33.00 M$17.00 M$41.00 M
Gross Profit +$28.00 M$160.00 M$26.00 M$33.00 M$17.00 M$41.00 M
Operating Income -$122.00 M-$8.00 M-$142.00 M-$114.00 M-$134.00 M-$96.00 M
EBITDA -$119.00 M-$6.00 M-$140.00 M-$111.00 M-$132.00 M-$93.00 M
Interest Expense -$1.00 M-$2.00 M-$3.00 M-$2.00 M-$3.00 M-$3.00 M
Depreciation $3.00 M$2.00 M$2.00 M$3.00 M$2.00 M$3.00 M
Income Before Tax -$112.00 M$0-$135.00 M-$106.00 M-$128.00 M-$91.00 M
Income Tax Expense $0$0$0$0$0$0
Net Income +-$112.00 M$0-$135.00 M-$106.00 M-$128.00 M-$91.00 M
Net Profit Margin -400%0%-519.23%-321.21%-752.94%-221.95%

Arcus Biosciences, Inc. Financials Balance Sheet In USD

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Share Capital $1.77 B$1.79 B$1.81 B$2.12 B$2.14 B$2.17 B
Reserve & Surplus -$1.24 B-$1.24 B-$1.38 B-$1.49 B-$1.61 B-$1.71 B
Non-Current Liabilities $433.00 M$316.00 M$303.00 M$277.00 M$264.00 M$262.00 M
Current Liabilities $192.00 M$210.00 M$235.00 M$231.00 M$209.00 M$198.00 M
Total Liabilities $625.00 M$526.00 M$538.00 M$508.00 M$473.00 M$460.00 M
Fixed Assets $46.00 M$44.00 M$42.00 M$40.00 M$38.00 M$36.00 M
Current Assets $1.03 B$946.00 M$857.00 M$1.01 B$844.00 M$756.00 M
Total Assets $1.16 B$1.07 B$974.00 M$1.14 B$997.00 M$924.00 M

Arcus Biosciences, Inc. Cash Flow

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Net Income -$112.00 M$0-$135.00 M-$106.00 M-$128.00 M-$91.00 M
Operating Cash Flow -$132.00 M-$133.00 M-$97.00 M-$120.00 M-$138.00 M-$119.00 M
Investing Cash Flow $32.00 M$137.00 M$79.00 M-$182.00 M$114.00 M$52.00 M
Financing Cash Flow $142.00 M$52.00 M$8.00 M$286.00 M$3.00 M$16.00 M
Change in Cash $42.00 M$56.00 M-$10.00 M-$16.00 M-$21.00 M-$51.00 M

Arcus Biosciences, Inc. Return Calculator

The Arcus Biosciences, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$6,966
Invested Amount$10,000
Est. Returns$-3,034
Invest in USA Stock Today

About Arcus Biosciences, Inc.

Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.

FAQs

Arcus Biosciences, Inc. (RCUS) share price as of September 18, 2026 is $25.35. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Arcus Biosciences, Inc. (RCUS) Share by opening an international trading account with Angel One.
Purchasing Arcus Biosciences, Inc. (RCUS) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Arcus Biosciences, Inc. (RCUS) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Arcus Biosciences, Inc. (RCUS) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Arcus Biosciences, Inc. on September 18, 2026, is $3.14 B.
Arcus Biosciences, Inc. operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in Arcus Biosciences, Inc. (RCUS) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Top US Stocks

VIEW ALL

Open Free Demat Account!

Join our 3.8 Cr+ happy customers
+91